Therapeutic biomarkers in metastatic castration-resistant prostate cancer: does the state matter?

Slootbeek, Peter H J; Tolmeijer, Sofie H; Mehra, Niven; Schalken, Jack A

Slootbeek, Peter H J; Tolmeijer, Sofie H; Mehra, Niven; Schalken, Jack A.

Afiliación

Slootbeek PHJ; Department of Medical Oncology, Radboud university medical center, Nijmegen, The Netherland.
Tolmeijer SH; Department of Medical Oncology, Radboud university medical center, Nijmegen, The Netherland.
Mehra N; Department of Medical Oncology, Radboud university medical center, Nijmegen, The Netherland.
Schalken JA; Department of Experimental Urology, Research Institute of Medical Innovation, Radboud university medical center, Nijmegen, The Netherlands.

Crit Rev Clin Lab Sci ; : 1-27, 2023 Oct 26.

Article en En | MEDLINE | ID: mdl-37882463

Palabras clave

DNA damage repair; Metastatic castration resistant prostate cancer; circulating tumor DNA; precision oncology; targeted therapy

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Idioma: En Revista: Crit Rev Clin Lab Sci Asunto de la revista: TECNICAS E PROCEDIMENTOS DE LABORATORIO Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google